Fundz

Marella Thorell Resigns as EVP and CFO of Seres Therapeutics

PUBLIC · MCRBOct 26, 2026

Position

Chief Financial Officer

Company

Seres Therapeutics

Marella Thorell
CambridgeBiotechnologyHealth CareTherapeutics

Description

On October 22, 2026, Marella Thorell announced her resignation from her role as Executive Vice President and Chief Financial Officer of Seres Therapeutics, effective November 15, 2026. After her departure, she will provide advisory services to support a smooth transition. The terms of her advisory services are yet to be finalized.

Quick answer

Marella Thorell Resigns as EVP and CFO of Seres Therapeutics (October 26, 2026). Seres Therapeutics is based in Cambridge, Massachusetts, United States.

What did Seres Therapeutics announce on October 26, 2026?
On October 22, 2026, Marella Thorell announced her resignation from her role as Executive Vice President and Chief Financial Officer of Seres Therapeutics, effective November 15, 2026. After her departure, she will provide advisory services to support a smooth transition.
What does Seres Therapeutics do?
Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage company developing novel microbiome therapeutics for serious diseases.
Where is Seres Therapeutics based?
Seres Therapeutics is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Estrella Immunopharma (October 26, 2026), Azora Therapeutics, Inc. (DE) (October 26, 2026), Cantargia AB (October 26, 2026) and Faeth Therapeutics (October 27, 2026) also announced leadership changes within 45 days of Seres Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Seres Therapeutics, and when

A new leader at Seres Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Seres Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Seres Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Seres Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Seres Therapeutics

Location

200 Sidney Street

Cambridge, Massachusetts, United States

About

Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Seres’ lead program, VOWST™, obtained U.S. FDA approval in April 2023 as the first orally administered microbiome therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Seres Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Matthew
Senior decision-maker at this company
••••••••@••••••••

See Matthew's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Seres Therapeutics's next move

Learn about Strategic plan

Seres Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.